Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer

Histone acetylation is a critical process in the regulation of chromatin structure and gene expression. Histone deacetylases (HDACs) remove the acetyl group, leading to chromatin condensation and transcriptional repression. HDAC inhibitors are considered a new class of anticancer agents and have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Danqi, Shen, Aijun, Fang, Guanghua, Liu, Hongchun, Zhang, Minmin, Tang, Shuai, Xiong, Bing, Ma, Lanping, Geng, Meiyu, Shen, Jingkang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724696/
https://www.ncbi.nlm.nih.gov/pubmed/26904403
http://dx.doi.org/10.1016/j.apsb.2015.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724696/
https://www.ncbi.nlm.nih.gov/pubmed/26904403
http://dx.doi.org/10.1016/j.apsb.2015.11.002

Ejemplares similares